Screener
CONMED CNMD Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: CONMED’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:13 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000816956-26-000102
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies | ||
| Shareholders' equity: | ||
| Preferred stock, par value $0.01 per share; | ||
| authorized 500,000 shares; none outstanding | — | — |
| Common stock, par value $0.01 per share;100,000,000 shares authorized; 31,299,194 sharesissued in 2026 and 2025, respectively | 313 | 313 |
| Paid-in capital | 513,464 | 503,200 |
| Retained earnings | 625,665 | 588,766 |
| Accumulated other comprehensive loss | (43,372) | (46,295) |
Item 1. Financial Statements (unaudited)
FAQ
- What is CONMED's preferred stock, shares authorized?
- CONMED (CNMD) reported preferred stock, shares authorized of $500K in Q2 2026.
- How has CONMED's preferred stock, shares authorized changed year-over-year?
- CONMED's preferred stock, shares authorized decreased by 0.0% year-over-year, from $500K to $500K.
- What is the long-term trend for CONMED's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), CONMED's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $500K to $500K.
Ask your AI about CONMED's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude